Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about those conducting the study.SummaryDifference2%
- Check53 days agoChange DetectedSeveral links related to rare diseases and clinical trials have been removed, including key resources from NIH and Dailymed, which may impact access to important medical information.SummaryDifference3%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, with new resources added including links to clinical trials, disease information, and data download options, while the previous version v2.12.1 has been removed.SummaryDifference4%
- Check75 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.